Correlations between the level of high-sensitivity C-reactive protein and cardiovascular risk factors in Korean adults with cardiovascular disease or diabetes mellitus: The CALLISTO study

Journal of Atherosclerosis and Thrombosis

Volumn 20, Issue 7, 2013, Pages 616-622

  Seo, Suk Min ^a   Baek, Sang Hong ^a   Jeon, Hui Kyung ^a   Kang, Seok Min ^b   Kim, Dong Soo ^c   Kim, Woo Shik ^d   Kim, Hyung Seop ^e   Rha, Seung Woon ^f   Park, Jong Seon ^g   Seong, Whan ^h   Ahn, Young Keun ⁱ   Yoon, Jung Han ^j   Cha, Tae Joon ^k  

^a The Catholic University of Korea   (South Korea)

^b Yonsei University College of Medicine   (South Korea)

^c Inje University College of Medicine   (South Korea)

^d Kyung Hee University Hospital   (South Korea)

^e Keimyung University   (South Korea)

^f Korea University College of Medicine   (South Korea)

^g Yeungnam University College of Medicine   (South Korea)

^h Chungnam National University College of Medicine   (South Korea)

ⁱ Chonnam National University Medical School   (South Korea)

^j Wonju Severance Christian Hospital   (South Korea)

^k Kosin University College of Medicine   (South Korea)

more..

Author keywords

Cardiovascular diseases; Cardiovascular risk factor; High sensitivity C reactive protein

Indexed keywords

C REACTIVE PROTEIN; CHOLESTEROL; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGE; ARTICLE; BODY MASS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CORRELATIONAL STUDY; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; FRAMINGHAM RISK SCORE; HUMAN; HYPERTENSION; INCIDENCE; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; PREVALENCE; SMOKING;

EID: 84880959806     PISSN: 13403478     EISSN: 18803873     Source Type: Journal    
DOI: 10.5551/jat.16089     Document Type: Article

References (29)

1. Wilson PWF, D'Agostino RB, Levy D, Belanger AM, Silbershartz H, Kannel WB: Prediction of coronary heart disease using risk factor categories. Circulation, 1998; 97: 1837-1847
2. LaRosa JC, He J, Vupputuri S: Effect of statins on risk of coronary disease: a meta-analysis of randomized controlled trials. JAMA, 1999; 282: 2340-2346
3. Sachdeva A, Cannon CP, Deedwania PC, Labresh KA, Smith SC Jr, Dai D, Hernandez A, Fonarow GC: Lipid levels in patients hospitalized with coronary artery disease: an analysis of 136,905 hospitalizations in Get With The Guidelines. Am Heart J, 2009; 157: 111-117
4. Hansson GK: Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med, 2005; 352: 1685-1695
5. Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH: Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med, 1997; 336: 973-979
6. Koenig W, Sund M, Fröhlich M, Fischer HG, Löwel H, Döring A, Hutchinson WL, Pepys MB: C-Reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middleaged men: results from the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) Augsburg Cohort Study, 1984 to 1992. Circulation, 1999; 99: 237-242
7. Ridker PM, Rifai N, Clearfield M, Downs JR, Weis SE, Miles JS, Gotto AM Jr; Air Force/Texas Coronary Atherosclerosis Prevention Study Investigators: Measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events. Air Force/Texas Coronary Atherosclerosis Prevention Study Investigators. N Engl J Med, 2001; 344: 1959-1965
8. Ridker PM, Rifai N, Rose L, Buring JE, Cook NR: Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med, 2002; 347: 1557-1565
9. Kim HJ, Pae SW, Kim DJ, Kim SK, Kim SH, Rhee YM, Chung SS, Ahn CW, Cha BS, Song YD, Lim SK, Kim KR, Hyun CL, Huh KB: Association of serum high sensitivity C-reactive protein with risk factors of cardiovascular diseases in type 2 diabetic and nondiabetic subjects without cardiovascular diseases. Korean J Med, 2002; 63: 36-45
10. Ryu SY, Lee YS, Park J, Kang MG, Kim KS: Relations of plasma high-sensitivity C-reactive protein to various cardiovascular risk factors. J Korean Med Sci, 2005; 20: 379-383
11. Executive Summary of the Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA, 2001; 285: 2486-2497
12. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation, 2002; 106: 3143-3421
13. Szmitko PE, Wang CH, Weisel RD, de Almeida JR, Anderson TJ, Verma S: New markers of inflammation and endothelial cell activation: Part I. Circulation, 2003; 108: 1917-1923
14. Momiyama Y, Ohmori R, Fayad ZA, Kihara T, Tanaka N, Kato R, Taniguchi H, Nagata M, Nakamura H, Ohsuzu F: Associations between plasma C-reactive protein levels and the severities of coronary and aortic atherosclerosis. J Atheroscler Thromb, 2010; 17: 460-467
15. Corrado E, Rizzo M, Coppola G, Fattouch K, Novo G, Marturana I, Ferrara F, Novo S. An update on the role of markers of inflammation in atherosclerosis. J Atheroscler Thromb, 2010; 17: 1-11
16. Iso H, Noda H, Ikeda A, Yamagishi K, Inoue M, Iwasaki M, Tsugane S for the JPHC Study Group: The impact of C-reactive protein on risk of stroke, stroke subtypes and ischemic heart disease in middle-aged Japanese: the Japan Public Health Center-based Study. J Atheroscler Thromb, 2012; 19: 756-766
17. Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH: Plasma concentration of C-reactive protein and risk of developing peripheral vascular disease. Circulation, 1998; 97: 425-428
18. Rohde LE, Hennekens CH, Ridker PM: Survey of C-reactive protein and cardiovascular risk factors in apparently healthy men. Am J Cardiol, 1999; 84: 1018-1022
19. Ridker PM, Cannon CP, Morrow D, Rifai N, Rose LM, McCabe CH, Pfeffer MA, Braunwald E; Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis in Myocardial Infarction 22 (PROVE IT-TIMI 22) Investigators: C-reactive protein levels and outcomes after statin therapy. N Engl J Med, 2005; 352: 20-28
20. Koenig W, Löwel H, Baumert J, Meisinger C: C-reactive protein modulates risk prediction based on the Framingham Score: implications for future risk assessment: results from a large cohort study in southern Germany. Circulation, 2004; 109: 1349-1353
21. Mora S, Rifai N, Buring JE, Ridker PM: Additive value of immunoassay-measured fibrinogen and high-sensitivity C-reactive protein levels for predicting incident cardiovascular events. Circulation, 2006; 114: 381-387
22. Barter P, Gotto AM, LaRosa JC, Maroni J, Szarek M, Grundy SM, Kastelein JJ, Bittner V, Fruchart JC; Treating to New Targets Investigators: HDL cholesterol, very low levels of LDL cholesterol, and cardiovascular events. N Engl J Med, 2007; 357: 1301-1310
23. Frost PH, Davis BR, Burlando AJ, Curb JD, Guthrie GP Jr, Isaacsohn JL, Wassertheil-Smoller S, Wilson AC, Stamler J: Serum lipids and incidence of coronary heart disease. Findings from the Systolic Hypertension in the Elderly Program (SHEP). Circulation, 1996; 94: 2381-2388
24. Lamarche B, Després JP, Moorjani S, Cantin B, Dagenais GR, Lupien PJ: Triglycerides and HDL-cholesterol as risk factors for ischemic heart disease. Results from the Québec cardiovascular study. Atherosclerosis, 1996; 119: 235-245
25. Manninen V, Tenkanen L, Koskinen P, Huttunen JK, Mänttäri M, Heinonen OP, Frick MH: Joint effects of serum triglyceride and LDL cholesterol and HDL cholesterol concentrations on coronary heart disease risk in the Helsinki Heart Study. Implications for treatment. Circulation, 1992; 85: 37-45
26. Wang TD, Chen WJ, Chien KL, Seh-Yi Su SS, Hsu HC, Chen MF, Liau CS, Lee YT: Efficacy of cholesterol levels and ratios in predicting future coronary heart disease in a Chinese population. Am J Cardiol, 2001; 88: 737-743
27. van der Meer IM, de Maat MP, Kiliaan AJ, van der Kuip DA, Hofman A, Witteman JC: The value of C-reactive protein in cardiovascular risk prediction: the Rotterdam Study. Arch Intern Med, 2003; 163: 1323-1328
28. Tohidi M, Hadaegh F, Harati H, Azizi F: C-reactive protein in risk prediction of cardiovascular outcomes: Tehran Lipid and Glucose Study. Int J Cardiol, 2009; 132: 369-374
29. Elliott P, Chambers JC, Zhang W, Clarke R, Hopewell JC, Peden JF, Erdmann J, Braund P, Engert JC, Bennett D, Coin L, Ashby D, Tzoulaki I, Brown IJ, Mt-Isa S, McCarthy MI, Peltonen L, Freimer NB, Farrall M, Ruokonen A, Hamsten A, Lim N, Froguel P, Waterworth DM, Vollenweider P, Waeber G, Jarvelin MR, Mooser V, Scott J, Hall AS, Schunkert H, Anand SS, Collins R, Samani NJ, Watkins H, Kooner JS: Genetic loci associated with C-reactive protein levels and risk of coronary heart disease. JAMA, 2009; 302: 37-48